Article ID Journal Published Year Pages File Type
8707129 Oral Oncology 2018 5 Pages PDF
Abstract
Chemoradiation may offer a survival benefit for non-oropharyngeal intermediate-risk advanced-stage HNC patients <70 years of age with T1-4N2-3 disease, but may not benefit those ≥70 years of age or those with T3-4N0-1 disease.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Dentistry, Oral Surgery and Medicine
Preview
Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age
Authors
, , , ,